# Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

> **NCT03793985** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 45 (actual)

## Conditions studied

- Hyperlipidemias

## Interventions

- **DRUG:** T
- **DRUG:** R

## Key facts

- **NCT ID:** NCT03793985
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2018-10-23
- **Final completion:** 2018-11-13
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03793985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03793985, "Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03793985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*